ConductScience.org, home

Paper32052028

Wortmannin, a specific inhibitor of phosphatidylinositol-3-kinase, induces accumulation of DNA double-strand breaks.

Ihara M and 3 others. J Radiat Res, 2020. Cited by 26 papers, by iCite.

Cite this record

ConductScience Library. Wortmannin, a specific inhibitor of phosphatidylinositol-3-kinase, induces accumulation of DNA double-strand breaks. Papers, record 32052028. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32052028

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Wortmannin, a specific inhibitor of phosphatidylinositol-3-kinase, induces accumulation of DNA double-strand breaks.
PubMed
Journal
J Radiat Res
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
26
iCite
Relative citation ratio, by iCite
1.26
iCite
Revised in PubMed
2020-12-14
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ihara MMakoto
2Shichijo KKazuko
3Takeshita SSatoshi
4Kudo TTakashi

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DNA Breaks, Double-StrandedMajor topic
Phosphatidylinositol 3-KinaseMajor topic
Protein Kinase InhibitorsMajor topic
WortmanninMajor topic
Animals
Cell Line
Cell Survival
Histones
Humans
Phosphorylation
Radiation Tolerance

Source PubMed

Download CSV of topics

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19766667Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin.Cancer Res1998https://conductscience.org/library/papers/9766667PubMed
22215662The scid mutation in mice causes a general defect in DNA repair.Nature1990https://conductscience.org/library/papers/2215662PubMed
319576233DNA double-strand breaks: their production, recognition, and repair in eukaryotes.Mutat Res2009https://conductscience.org/library/papers/19576233PubMed
411242102DNA double-strand breaks: signaling, repair and the cancer connection.Nat Genet2001https://conductscience.org/library/papers/11242102PubMed
512410360Wortmannin inhibits growth of human non-small-cell lung cancer in vitro and in vivo.Langenbecks Arch Surg2002https://conductscience.org/library/papers/12410360PubMed
616828758Quantitative measurement of hydroxyl radical induced DNA double-strand breaks and the effect of N-acetyl-L-cysteine.FEBS Lett2006https://conductscience.org/library/papers/16828758PubMed
718610740Gamma-H2AX - a novel biomarker for DNA double-strand breaks.In Vivo2008https://conductscience.org/library/papers/18610740PubMed
89815794Radiosensitization of human tumor cells by the phosphatidylinositol3-kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay.Clin Cancer Res1997https://conductscience.org/library/papers/9815794PubMed
97889575Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation.Cell1995https://conductscience.org/library/papers/7889575PubMed
1024000320DNA double strand break repair via non-homologous end-joining.Transl Cancer Res2013https://conductscience.org/library/papers/24000320PubMed
116823332A severe combined immunodeficiency mutation in the mouse.Nature1983https://conductscience.org/library/papers/6823332PubMed
1211571274ATM phosphorylates histone H2AX in response to DNA double-strand breaks.J Biol Chem2001https://conductscience.org/library/papers/11571274PubMed
138542574The phosphatidylinositol 3-kinase inhibitor wortmannin sensitizes murine fibroblasts and human tumor cells to radiation and blocks induction of p53 following DNA damage.Cancer Res1996https://conductscience.org/library/papers/8542574PubMed
1425104768Sources of DNA double-strand breaks and models of recombinational DNA repair.Cold Spring Harb Perspect Biol2014https://conductscience.org/library/papers/25104768PubMed
156828386Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.Nucleic Acids Res1983https://conductscience.org/library/papers/6828386PubMed
1627884168Ataxia telangiectasia: a review.Orphanet J Rare Dis2016https://conductscience.org/library/papers/27884168PubMed
178162590Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase.Cancer Res1994https://conductscience.org/library/papers/8162590PubMed
187671312DNA-dependent protein kinase catalytic subunit: a relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product.Cell1995https://conductscience.org/library/papers/7671312PubMed
1922569912Role of non-homologous end joining in V(D)J recombination.Immunol Res2012https://conductscience.org/library/papers/22569912PubMed
2012792649Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks.Nat Cell Biol2003https://conductscience.org/library/papers/12792649PubMed

See all 38 referencesDownload CSV of references

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.

PMIDTitleJournalYearIn PapersSource
42984918Targeting ATM Kinase in Cancer-A Comprehensive Review.Oncol Res2026https://conductscience.org/library/papers/42984918PubMed
42044355All you need is fungi: Exploring secondary metabolites as a source of novel amoebicidal agents.Genet Mol Biol2026https://conductscience.org/library/papers/42044355PubMed
41896658The application of nanoparticle-mediated siRNA delivery systems in ovarian cancer.Cancer Gene Ther2026https://conductscience.org/library/papers/41896658PubMed
41552486PI3K/AKT/eNOS Modulation and Angiotensin II Suppression by Dryopteris crassirhizoma Rhizome Extract: Computational and Experimental Evidence.ACS Omega2026https://conductscience.org/library/papers/41552486PubMed
41357583Norrin in cancer: from a promising prognostic biomarker to a novel therapeutic target.Front Oncol2025https://conductscience.org/library/papers/41357583PubMed
41306662Key Nano-Strategies for Cisplatin Resistance in Advancing Anti-Cancer Therapy.Int J Nanomedicine2025https://conductscience.org/library/papers/41306662PubMed
40868982Tetraarsenic Hexoxide Enhanced the Anticancer Effects of Artemisia annua L. Polyphenols by Inducing Autophagic Cell Death and Apoptosis in Oxalplatin-Resistant HCT116 Colorectal Cancer Cells.Int J Mol Sci2025https://conductscience.org/library/papers/40868982PubMed
40402380Autophagy mediated immune response regulation and drug resistance in cancer.Mol Biol Rep2025https://conductscience.org/library/papers/40402380PubMed
39902073Cynaroside ameliorates TNBS-induced colitis by inhibiting intestinal epithelial cell apoptosis via the PI3K/AKT signalling pathway.Front Pharmacol2024https://conductscience.org/library/papers/39902073PubMed
39854096AGDMP1 alleviates insulin resistance by modulating heat shock protein 60-mediated IRS-1/AKT/GLUT4 pathway and adipose inflammation: A potential therapeutic peptide for gestational diabetes mellitus.FASEB J2025https://conductscience.org/library/papers/39854096PubMed
39350337DrugReSC: targeting disease-critical cell subpopulations with single-cell transcriptomic data for drug repurposing in cancer.Brief Bioinform2024https://conductscience.org/library/papers/39350337PubMed
38732504Inhibition of Prostate Cancer Cell Survival and Proliferation by Carnosic Acid Is Associated with Inhibition of Akt and Activation of AMPK Signaling.Nutrients2024https://conductscience.org/library/papers/38732504PubMed
38275055Targeted Mevalonate Pathway and Autophagy in Antitumor Immunotherapy.Curr Cancer Drug Targets2024https://conductscience.org/library/papers/38275055PubMed
35645792Rosmarinic Acid Ameliorates Pulmonary Ischemia/Reperfusion Injury by Activating the PI3K/Akt Signaling Pathway.Front Pharmacol2022https://conductscience.org/library/papers/35645792PubMed
35018228The biochemical and clinical implications of phosphatase and tensin homolog deleted on chromosome ten in different cancers.Am J Cancer Res2021https://conductscience.org/library/papers/35018228PubMed
34415239Identification of effective natural PIK3CA H1047R inhibitors by computational study.Aging (Albany NY)2021https://conductscience.org/library/papers/34415239PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ATM472PubTator's text mininghttps://conductscience.org/library/genes/472NCBI Gene
H2AX3014PubTator's text mininghttps://conductscience.org/library/genes/3014NCBI Gene
PIK3R15295PubTator's text mininghttps://conductscience.org/library/genes/5295NCBI Gene
PRKDC5591PubTator's text mininghttps://conductscience.org/library/genes/5591NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32052028

GET https://conductscience.org/api/papers/v1/32052028/references?page=2